Citation Impact
Citing Papers
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Accelerated regrowth of non-small-cell lung tumours after induction chemotherapy
2003
A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck
2006
Clinical impact of prolonged diagnosis to treatment interval (DTI) among patients with oropharyngeal squamous cell carcinoma
2016
Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: Long-term results of Phase III clinical trial
2006
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results
2008 Standout
Repopulation of cancer cells during therapy: an important cause of treatment failure
2005
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Altered fractionation and combined radio-chemotherapy approaches
2003
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
Drug penetration in solid tumours
2006 Standout
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Merkel cell carcinoma
2017
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
2009 Standout
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial
2011
Radiotherapy and wound healing
2005
Results of a prospective randomised trial comparing conventional radiotherapy to split course bifractionated radiation therapy in patients with nasopharyngeal carcinoma
2007
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data
2009
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Merkel Cell Carcinoma: 30-Year Experience from a Single Institution
2012
Nasopharyngeal carcinoma
2015 Standout
Mortality due to cancer treatment delay: systematic review and meta-analysis
2020 Standout
The pathobiology of mucositis
2004 Standout
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial
2003
The relationship between waiting time for radiotherapy and clinical outcomes: A systematic review of the literature
2007
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
2016 Standout
Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy—a multicenter randomized trial
2002
Concomitant radiochemotherapy or accelerated radiotherapy: Analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC)
2004
Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial
2004
Radiotherapy for cancer of the head and neck: altered fractionation regimens
2002
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
2009 Standout
The radiotherapeutic injury – a complex ‘wound’
2002
MERKEL CELL CARCINOMA: IMPROVED OUTCOME WITH ADJUVANT RADIOTHERAPY
2005
ROS and the DNA damage response in cancer
2018 Standout
Cancer as an evolutionary and ecological process
2006 Standout
Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
2014 Standout
Angiogenesis as a therapeutic target
2005 StandoutNature
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
2007 Standout
Quantitative proteomics reveals mitochondrial respiratory chain as a dominant target for carbon ion radiation: Delayed reactive oxygen species generation caused DNA damage
2018
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
T1-T2N0 Squamous Cell Carcinoma of the Glottic Larynx Treated With Radiation Therapy
2001
Merkel Cell Carcinoma: Prognosis and Treatment of Patients From a Single Institution
2005
Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United States
2008 Standout
Merkel Cell Carcinoma: Chemotherapy and Emerging New Therapeutic Options
2013
Phase III Randomized Trial of Very Accelerated Radiation Therapy Compared With Conventional Radiation Therapy in Squamous Cell Head and Neck Cancer: A GORTEC Trial
2006
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Works of Chris Hamilton being referenced
Does waiting time affect the outcome of larynx cancer treated by radiotherapy?
1997
Do inflammatory processes contribute to radiation induced erythema observed in the skin of humans?
1998
Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group study
2001
A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study
2001
Dosimetric intercomparison for two Australasian clinical trials using an anthropomorphic phantom
2002
Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?
2005
The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neck
2003
High-Risk Merkel Cell Carcinoma of the Skin Treated With Synchronous Carboplatin/Etoposide and Radiation: A Trans-Tasman Radiation Oncology Group Study—TROG 96:07
2003
The use of fiducial markers in image‐guided radiotherapy for gastric cancer
2013